Approvals/TGA/VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle

Approved

STANDARD

VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 56d92d55dd452cb6
Product Name: VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle
Artg Id: 220174
Artg Name: VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2014-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

56d92d55dd452cb6

Type

Standard